Studies of glycosaminoglycan composition and biologic activity of Vessel®, a hypolipidemic agent
- 1 October 1978
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 31 (2) , 217-229
- https://doi.org/10.1016/0021-9150(78)90167-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Long-term Heparin Treatment in Ischaemic Heart DiseaseActa Medica Scandinavica, 2009
- Coronary Heart Disease and the Mucopolysaccharides (Glycosaminoglycans)Southern Medical Journal, 1976
- Glycosaminoglycans from Ateroid® and bovine duodenal mucosa and pancreasMolecular and Cellular Biochemistry, 1975
- Lipoprotein-acid mucopolysaccharide complexes of human atherosclerotic lesionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975
- Isolation of lipoprotein-acid mucopolysaccharide complexes from fatty streaks of human aortasAtherosclerosis, 1972
- Evidence for an ionic binding of lipoprotein lipase to heparinBiochemical and Biophysical Research Communications, 1971
- Inhibition of atherosclerosis in cholesterol-fed rabbits by a heparitin sulfate: Preliminary communicationAtherosclerosis, 1971
- Complexing of serum pre-β- and β-lipoproteins and acid mucopolysaccharidesAtherosclerosis, 1970
- A Simplified Technique for Semiquantitative, Clinical Estimation of Serum β-and Pre-β-LipoproteinsJournal of Vascular Research, 1970
- A Controlled Study of the Effect of Intermittent Heparin Therapy on the Course of Human Coronary AtherosclerosisCirculation, 1956